As of 4:01pm ET
| -0.92 / -2.04%|
The 31 analysts offering 12-month price forecasts for Fresenius Medical Care AG & Co KGaA have a median target of 50.51, with a high estimate of 58.05 and a low estimate of 35.92. The median estimate represents a +14.38% increase from the last price of 44.16.
The current consensus among 33 polled investment analysts is to Buy stock in Fresenius Medical Care AG & Co KGaA. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.